Portopulmonary hypertension echocardiography or ultrasound

Portopulmonary hypertension Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Portopulmonary hypertension from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Portopulmonary hypertension echocardiography or ultrasound On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Portopulmonary hypertension echocardiography or ultrasound All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Portopulmonary hypertension echocardiography or ultrasound
CDC on Portopulmonary hypertension echocardiography or ultrasound
Portopulmonary hypertension echocardiography or ultrasound in the news
Blogs on Portopulmonary hypertension echocardiography or ultrasound
Directions to Hospitals Treating Portopulmonary hypertension
Risk calculators and risk factors for Portopulmonary hypertension echocardiography or ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Echocardiography

The diagnosis of portopulmonary hypertension is based on hemodynamic criteria:

1. . Portal hypertension and/or liver disease (clinical diagnosis—ascites/varices/splenomegaly)
2. . Mean pulmonary artery pressure—MPAP > 25 mmHg at rest
3. . Pulmonary vascular resistance—PVR > 240 dynes s cm−5
4. . Pulmonary artery occlusion pressure— PAOP < 15mmHg or transpulmonary gradient—TPG > 12 mmHg where TPG = MPAP − PAOP.

The diagnosis is usually first suggested by a transthoracic echocardiogram, part of the standard pre-transplantation work-up. Echocardiogram estimated pulmonary artery systolic pressures of 40 to 50 mm Hg are used as a screening cutoff for PPH diagnosis, with a sensitivity of 100% and a specificity as high as 96%. The negative predictive value of this method is 100% but the positive predictive value is 60%.